U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C4H4N2
Molecular Weight 80.088
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PYRIDAZINE

SMILES

C1=CN=NC=C1

InChI

InChIKey=PBMFSQRYOILNGV-UHFFFAOYSA-N
InChI=1S/C4H4N2/c1-2-4-6-5-3-1/h1-4H

HIDE SMILES / InChI

Molecular Formula C4H4N2
Molecular Weight 80.088
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

PubMed

PubMed

TitleDatePubMed
CoMFA based de novo design of pyridazine analogs as PTP1B inhibitors.
2007-07
Silver(I) sulfate coordination polymers with 4,4'-bipyridazine and pyridazino[4,5-d]pyridazine.
2007-06
Metabolism of prazosin in rat, dog, and human liver microsomes and cryopreserved rat and human hepatocytes and characterization of metabolites by liquid chromatography/tandem mass spectrometry.
2007-06
13C-1H HSQC experiment of probe molecules aligned in thermotropic liquid crystals: sensitivity and resolution enhancement in the indirect dimension.
2007-04
Luminescent hydrido-carbonyl clusters of rhenium containing bridging 1,2-diazine ligands.
2006-12-25
A self-assembled hexadecanuclear 4 x[2 x 2] Mn(II)16 square grid from a pyridazine bis(hydrazone) ligand: synthesis, structure and magnetism.
2006-12-21
Metal-organic frameworks exhibiting strong anion-pi interactions.
2006-12-14
Estimation of local density augmentation and hydrogen bonding between pyridazine and water under sub- and supercritical conditions using UV-vis spectroscopy.
2006-11
Donor-acceptor-donor-type liquid crystal with a pyridazine core.
2006-10-12
A computational study on pi and sigma modes of metal ion binding to heteroaromatics (CH)(5-m)X(m) and (CH)(6-m)X(m) (X = N and P): contrasting preferences between nitrogen- and phosphorous-substituted rings.
2006-08-24
Triphenylene analogues with B2N2C2 cores: synthesis, structure, redox behavior, and photophysical properties.
2006-08-23
Use of 4-bromo pyridazine 3,6-dione for building 3-amino pyridazine libraries.
2006-08
3-Benzidino-6(4-chlorophenyl) pyridazine blocks delayed rectifier and transient outward potassium current in acutely isolated rat hippocampal pyramidal neurons.
2006-07-10
Pulsed-field ionization electron spectroscopy and ab initio calculations of copper-diazine complexes.
2006-07-07
Copper complexes with heterocyclic sulfonamides: synthesis, spectroscopic characterization, microbiological and SOD-like activities: crystal structure of [Cu(sulfisoxazole)2(H2O)4] . 2H2O.
2006-07
A thienopyridazinone-based melanin-concentrating hormone receptor 1 antagonist with potent in vivo anorectic properties.
2006-06-29
Kinetics and mechanism of the reactions of Pd(II) complexes with azoles and diazines. Crystal structure of [Pd(bpma)(H2O)](ClO4)2.2H2O.
2006-06-28
The in vivo metabolism of 3-oxo-5-benzylidene-6-methyl-(4H)-2-(benzoylmethyl)pyridazine in rats.
2006-05-24
Anion-pi interactions as controlling elements in self-assembly reactions of Ag(I) complexes with pi-acidic aromatic rings.
2006-05-03
Determination of natural abundance 15N-1H and 13C-1H dipolar couplings of molecules in a strongly orienting media using two-dimensional inverse experiments.
2006-05
A pyridazine series of alpha2/alpha3 subtype selective GABA A agonists for the treatment of anxiety.
2006-04-20
Vibrational spectroscopy of the pyridazine cation in the ground state.
2006-03-02
Cadmium nitrate coordination polymers with substituted pyridazino[4,5-d]pyridazines.
2006-02
Pyrrolopyridazine MEK inhibitors.
2006-02
Synthetic approaches to polypyridyl bridging ligands with proximal multidentate binding sites.
2006-01-06
Monoclinic and triclinic concomitant polymorphs of di-mu-pyridazine-1kappa(2)N:2kappa(2)N'-bis[(saccharinato)silver(I)].
2006-01
Current status of anti-picornavirus therapies.
2006
Hydrogen bond directed synthesis of pyridazine and naphthyridine containing macrocycles.
2005-12-14
Mono- or diphenylpyridazines connected to N-(2,4-difluorophenyl)-N'-heptylurea as acyl-CoA:cholesterol acyltransferase inhibitors.
2005-12-01
Synthesis of new series of 1-Aryl-1,4-dihydro-4-oxo-6-methyl pyridazine-3-carboxylic acid as potential antibacterial agents.
2005-12
Interplay between intra- and interligand charge transfer with variation of the axial N-heterocyclic ligand in osmium(II) pyridylpyrazolate complexes: extensive color tuning by phosphorescent solvatochromism.
2005-10-21
Fully dimensional ab initio description of the structure and energetics of azabenzene-argon complexes.
2005-10-15
Cyclization reactions of acylium and thioacylium ions with isocyanates and isothiocyanates: gas phase synthesis of 3,4-dihydro-2,4-dioxo-2H-1,3,5-oxadiazinium ions.
2005-10
A new pyridazine series of GABAA alpha5 ligands.
2005-09-22
Vibrational spectra and potential energy distributions for 4,5-dichloro-3-hydroxypyridazine by density functional theory and normal coordinate calculations.
2005-09
Dye-sensitized photooxygenation of furanosyl furans: synthesis of a new pyridazine C-nucleoside.
2005-08-05
Total synthesis of ningalin D.
2005-08-03
Dimetallic complexes of a structurally versatile pyridazine-containing Schiff-base macrocyclic ligand with pendant pyridine arms.
2005-07-21
Design and synthesis of potent pyridazine inhibitors of p38 MAP kinase.
2005-05-02
Validation of the neuroinflammation cycle as a drug discovery target using integrative chemical biology and lead compound development with an Alzheimer's disease-related mouse model.
2005-04
Synthesis of 3-alkylthio-6-allylthiopyridazine derivatives and their antihepatocarcinoma activity.
2005-04
Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan acetylcholine binding protein (AChBP).
2005-04
Neutral Cu4N12 and Ag4N12 metallacycles with a para-cyclophane framework assembled from copper(I) and silver(I) pyrazolates and pyridazine.
2005-03-28
3,6-bis(2'-pyridyl)pyridazine (L) and its deprotonated form (L - H+)- as ligands for {(acac)2Ru(n+)} or {(bpy)2Ru(m+)}: investigation of mixed valency in [{(acac)2Ru}2(mu-L - H+)]0 and [{(bpy)2Ru}2(mu-L - H+)]4+ by spectroelectrochemistry and EPR.
2005-02-21
Synthesis and herbicidal activity of novel heterocyclic protoporphyrinogen oxidase inhibitors.
2004-12
5'-(2-phosphoryl-1,4-dioxobutane) as a product of 5'-oxidation of deoxyribose in DNA: elimination as trans-1,4-dioxo-2-butene and approaches to analysis.
2004-11
Pyridazine derivatives and related compounds. Part 13: Synthesis and antimicrobial activity of some pyridazino[3',4':3,4]pyrazolo[5,1-c]-1,2,4-triazines.
2004-10-04
Zonal ablation of the olfactory sensory neuroepithelium of the mouse: effects on odorant detection.
2004-10
The influence of water on the rates of 1,3-dipolar cycloaddition reactions: trigger points for exponential rate increases in water-organic solvent mixtures. Water-super versus water-normal dipolarophiles.
2004-09-29
N-Phenyl-4-pyrazolo[1,5-b]pyridazin-3-ylpyrimidin-2-amines as potent and selective inhibitors of glycogen synthase kinase 3 with good cellular efficacy.
2004-09-09
Patents
Substance Class Chemical
Created
by admin
on Mon Mar 31 20:54:34 GMT 2025
Edited
by admin
on Mon Mar 31 20:54:34 GMT 2025
Record UNII
449GLA0653
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
PYRIDAZINE
MI  
Systematic Name English
NSC-90792
Preferred Name English
PYRIDAZINE [MI]
Common Name English
OIZINE
Common Name English
1,2-DIAZINE
Systematic Name English
ORTHODIAZINE
Systematic Name English
Code System Code Type Description
FDA UNII
449GLA0653
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
CHEBI
30954
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
ECHA (EC/EINECS)
206-025-5
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
NSC
90792
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
WIKIPEDIA
PYRIDAZINE
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
CAS
289-80-5
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
EPA CompTox
DTXSID7059777
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
PUBCHEM
9259
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
MERCK INDEX
m9350
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY Merck Index
MESH
C062482
Created by admin on Mon Mar 31 20:54:34 GMT 2025 , Edited by admin on Mon Mar 31 20:54:34 GMT 2025
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY